curasan AG commences operations in the European market with the appointment of a marketing expert
(firmenpresse) - curasan AG / Key word(s): Enterprise/
curasan AG commences operations in the European market with the
appointment of a marketing expert
DGAP-Media / 15.02.2012 / 09:16
---------------------------------------------------------------------
curasan AG, listed in the General Standard (ISIN: DE 000 549 453 8),
created a new post on 1st February 2012 in relation to the active expansion
of its European sales network in the fields of Orthopaedics and trauma
surgery. Mr. Lee McCann BSc Business Administration (North West University
of Applied Science, London, U.K.), will be operating as the organisation's
International Sales Director for Orthobiologics with immediate effect.
Apart from possessing a sound knowledge of the Orthobiologics market, Mr.
McCann has considerable experience in international sales and corporate
development to take on the new challenge. This has been proven following
his work in these segments as the Business Development Manager, Europe for
biomaterials in spine surgery and as an International Marketing Manager for
such market-leading competitors as Orthovita Inc., Malvern, PA, USA, and
Apatech Ltd., London, U.K. In the process, he has successfully set up an
international sales network for medical products and, as a consequence,
motivated and supported the distributors.
'We will cooperate with different partners for sales in the most important
European countries. In order to choose the right companies and sign
contracts with them we require special experience' explained Hans Dieter
Rössler, Chairman and CEO of curasan AG. 'In Lee McCann, we have appointed
a professional who has already achieved this both successfully and
repeatedly in the Orthopaedics market. Based on his specific knowledge of
the industry and international experience, work on sales and marketing
activities in the most important European markets should begin in the
current year'.
Background information about curasan AG:
Exchange listed curasan AG (ISIN: DE 000 549 453 8) is one of the leading
companies in the field of regenerative medicine especially in bone and
tissue regeneration. The company has developed a future-oriented product
pipeline in synthetic bone substitutes and bone regeneration material. Some
of these various new developments are ready for market rollout. Further
products are about to follow within the next two years. These biomaterials
will be distributed in different submarkets by well-positioned contractual
partners. www.curasan.com
Contact:
curasan AG
Andrea Weidner
Tel. +49 (0)6027 40 900-51
Fax +49 (0)6027 40 900-39
andrea.weidner(at)curasan.de
www.curasan.de
fr financial relations gmbh
Jörn Gleisner
Tel. +49 (0)69 95 90 83 20
Fax +49 (0)69 95 90 83 99
j.gleisner(at)finanical-relations.de
End of Media Release
---------------------------------------------------------------------
15.02.2012 Dissemination of a Press Release, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: curasan AG
Lindigstraße 4
63801 Kleinostheim
Germany
Phone: 06027/40 900 0
Fax: 06027/40 900 29
E-mail: info(at)curasan.de
Internet: www.curasan.de
ISIN: DE0005494538
WKN: 549453
Listed: Regulierter Markt in Frankfurt (General Standard);
Freiverkehr in Berlin, Düsseldorf, Hamburg, München,
Stuttgart
End of News DGAP-Media
---------------------------------------------------------------------
156768 15.02.2012
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: EquityStory
" alt="Zimtu Capital Corp. announces Property Transaction with Strike Graphite Corp.Datum: 15.02.2012 - 09:16 Uhr
Sprache: Deutsch
News-ID 114770
Anzahl Zeichen: 4701
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 383 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"curasan AG commences operations in the European market with the appointment of a marketing expert"
steht unter der journalistisch-redaktionellen Verantwortung von
curasan AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
